Boundless Bio, Inc. (BOLD)
(Delayed Data from NSDQ)
$3.13 USD
-0.07 (-2.19%)
Updated Sep 6, 2024 04:00 PM ET
After-Market: $3.13 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth B Momentum D VGM
Cash flow Statements
Fiscal Year End for Boundless Bio, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -49.43 | -45.90 | NA | NA | NA |
Depreciation/Amortization & Depletion | 0.96 | 0.94 | NA | NA | NA |
Net Change from Assets/Liabilities | -0.80 | 0.87 | NA | NA | NA |
Net Cash from Discontinued Operations | 0.00 | 0.00 | NA | NA | NA |
Other Operating Activities | 2.42 | 4.50 | NA | NA | NA |
Net Cash From Operating Activities | -46.86 | -39.60 | NA | NA | NA |
Property & Equipment | -0.63 | -1.07 | NA | NA | NA |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | NA | NA | NA |
Investments | -37.63 | 17.20 | NA | NA | NA |
Other Investing Activities | 0.00 | 0.00 | NA | NA | NA |
Net Cash from Investing Activities | -38.26 | 16.13 | NA | NA | NA |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 99.85 | 0.13 | NA | NA | NA |
Issuance (Repayment) of Debt | 0.00 | 0.00 | NA | NA | NA |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | NA | NA | NA |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | NA | NA | NA |
Other Financing Activities | -1.96 | 0.00 | NA | NA | NA |
Net Cash from Financing Activities | 97.90 | 0.13 | NA | NA | NA |
Effect of Exchange Rate Changes | 0.00 | 0.00 | NA | NA | NA |
Net Change In Cash & Equivalents | 12.78 | -23.34 | NA | NA | NA |
Cash at Beginning of Period | 11.48 | 34.82 | NA | NA | NA |
Cash at End of Period | 24.27 | 11.48 | NA | NA | NA |
Diluted Net EPS | -40.65 | NA | NA | NA | NA |
Fiscal Year End for Boundless Bio, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -32.41 | -15.43 | -49.43 | NA | -24.12 |
Depreciation/Amortization & Depletion | 0.53 | 0.26 | 0.96 | NA | 0.48 |
Net Change from Assets/Liabilities | -2.17 | -1.58 | -0.80 | NA | -1.16 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | NA | 0.00 |
Other Operating Activities | 2.04 | 0.97 | 2.42 | NA | 1.83 |
Net Cash From Operating Activities | -32.01 | -15.78 | -46.86 | NA | -22.98 |
Property & Equipment | -1.59 | -0.08 | -0.63 | NA | -0.21 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | NA | 0.00 |
Investments | -48.47 | 18.22 | -37.63 | NA | -46.14 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | NA | 0.00 |
Net Cash from Investing Activities | -50.05 | 18.14 | -38.26 | NA | -46.36 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 93.06 | 0.06 | 99.85 | NA | 100.06 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | NA | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | NA | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | NA | 0.00 |
Other Financing Activities | -3.34 | -0.98 | -1.96 | NA | -0.33 |
Net Cash from Financing Activities | 89.72 | -0.92 | 97.90 | NA | 99.73 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | NA | 0.00 |
Net Change In Cash & Equivalents | 7.66 | 1.44 | 12.78 | NA | 30.39 |
Cash at Beginning of Period | 24.27 | 24.27 | 11.48 | NA | 11.48 |
Cash at End of Period | 31.92 | 25.70 | 24.27 | NA | 41.88 |
Diluted Net EPS | -0.77 | -12.27 | NA | NA | NA |